Neuroimaging of Dandy-Walker malformation: new concepts
GG Correa, LF Amaral, LM Vedolin - Topics in Magnetic …, 2011 - journals.lww.com
Dandy-Walker malformation (DWM) is the most common human cerebellar malformation,
characterized by hypoplasia of the cerebellar vermis, cystic dilation of the fourth ventricle, and …
characterized by hypoplasia of the cerebellar vermis, cystic dilation of the fourth ventricle, and …
MR imaging in spinocerebellar ataxias: a systematic review
…, TJR Rezende, LM Vedolin… - American Journal …, 2016 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Polyglutamine expansion spinocerebellar ataxias are
autosomal dominant slowly progressive neurodegenerative diseases with no current treatment. …
autosomal dominant slowly progressive neurodegenerative diseases with no current treatment. …
Neuroimaging findings in patients with mucopolysaccharidosis: what you really need to know
…, JA Pérez, JÁ Duarte, FA Leiria, M Anés, LM Vedolin - Radiographics, 2016 - pubs.rsna.org
Mucopolysaccharidosis (MPS) is an inherited metabolic disease and a member of the group
of lysosomal storage disorders. Its hallmark is a deficiency of lysosomal enzymes involved …
of lysosomal storage disorders. Its hallmark is a deficiency of lysosomal enzymes involved …
Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke
…, MD Araújo, C Klamt, L Vedolin… - Cell …, 2012 - journals.sagepub.com
Transplantation of autologous bone marrow mononuclear cells (BMMCs) has been proven
safe in animal and human studies. However, there are very few studies in stroke patients. In …
safe in animal and human studies. However, there are very few studies in stroke patients. In …
Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression
…, A John, LB Jardim, LM Vedolin… - American journal of …, 2008 - Wiley Online Library
… CSF GAG results revealed pretreatment values slightly above normal standards: 13.3 mg/L
(NV < 12 mg/L) which after IT laronidase infusions were within normal levels (10.3 mg/L). …
(NV < 12 mg/L) which after IT laronidase infusions were within normal levels (10.3 mg/L). …
[HTML][HTML] Guidelines for acute ischemic stroke treatment: part I
…, VF Zétola, RJ Gagliardi, L Vedolin… - Arquivos de neuro …, 2012 - SciELO Brasil
… Executive Committee: Charles André, Aroldo Luiz Bacellar, Daniel da Cruz Bezerra, Roberto
Campos, João José Freitas de Carvalho, Gabriel Rodrigues de Freitas, Roberto de Magalhães …
Campos, João José Freitas de Carvalho, Gabriel Rodrigues de Freitas, Roberto de Magalhães …
Validation of a smartphone application in the evaluation and treatment of acute stroke in a comprehensive stroke center
…, MABC Rockenbach, FM Gonçalves, LM Vedolin… - Stroke, 2020 - Am Heart Assoc
Background and Purpose— The increasing demand and shortage of experts to evaluate and
treat acute stroke patients has led to the development of remote communication tools to aid …
treat acute stroke patients has led to the development of remote communication tools to aid …
Brain MRI in mucopolysaccharidosis: effect of aging and correlation with biochemical findings
L Vedolin, IVD Schwartz, M Komlos, A Schuch… - Neurology, 2007 - AAN Enterprises
Objective: To investigate the influence of aging on conventional MRI and magnetic resonance
spectroscopy (MRS) findings of mucopolysaccharidosis (MPS) patients and to test the …
spectroscopy (MRS) findings of mucopolysaccharidosis (MPS) patients and to test the …
Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II
L Vedolin, IVD Schwartz, M Komlos… - American Journal …, 2007 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: There are no reliable markers to predict neurologic outcome
of patients with mucopolysaccharidosis (MPS) II. We hypothesized that brain MR imaging …
of patients with mucopolysaccharidosis (MPS) II. We hypothesized that brain MR imaging …
CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy
L Jardim, L Vedolin, IVD Schwartz, MG Burin… - Journal of inherited …, 2004 - Springer
We report the clinical and radiological central nervous system (CNS) findings of 8 Fabry
disease patients, before (8/8) and after (7/8) 12 months of enzyme replacement therapy (ERT) …
disease patients, before (8/8) and after (7/8) 12 months of enzyme replacement therapy (ERT) …
